Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MEK114375 rollover study of GSK1120212 in solid tumors and leukemia
2010-023015-33Phase 2Completed
- Sponsor
- GSK
- Start
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of trametinib in cancer, Nonhematologic neoplasms, leukemia and 1 more, sponsored by GSK. Primary endpoint: Continued access to trametinib. Started Jul 2012; status: completed.
02
Drugs
trametinib
03
Conditions
cancerNonhematologic neoplasmsleukemiamelanoma
Beyond the preview
Go deeper on 2010-023015-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023015-33.